Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study

Lavery A., Stevenson L., McManus D., Gemma E L., M Walker S., Van Schaeybroeck S., VIRDEE P., ELHUSSEIN L., Turbitt J., Miedzybrodzka Z., Petty R., Harkin PD., Kennedy RD., Eatock MM., MIDDLETON M., Thomas A., Turkington RC.

Type

Conference paper

Publication Date

29/03/2020

Permalink